Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group

Michael A. Bookman*, Kathleen M. Darcy, Daniel Clarke-Pearson, Richard A. Boothby, Ira R. Horowitz

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

555 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences